Loading company…
Riskpilot
← Back to search
Sign in
Get full access
KAB Biotech Holding ApS
APS
In liquidation
CVR 37692646
Langelinie Allé 35
Ikke-finansielle holdingselskaber · NACE 642020
Est. 2016
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2019
DKK -17K
0% vs 2018
EBITDA margin
100.0%
-100% vs 2018
Equity ratio
94.0%
Financial strength
Net profit 2019
DKK 7,5M
-25% vs 2018
EBITDA — year on year
DKK millions
0M
4M
8M
11M
15M
3M
2016
0M
-100%
2017
12M
+1200%
2018
0M
-100%
2019
Key figures
Annual report 2019
Revenue
DKK -17K
+0%
EBITDA
DKK -17K
-100%
Net profit
DKK 7,5M
-25%
Total assets
DKK 26,2M
+52%
Equity
DKK 24,6M
+44%
Employees
—
—
Company information
Legal name
KAB Biotech Holding ApS
CVR number
37692646
Legal form
Anpartsselskab
NACE code
642020 · Ikke-finansielle holdingselskaber
Founded
18. maj 2016
Share capital
DKK 1.444.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2019-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Contact
Address
Langelinie Allé 35
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Ikke-finansielle holdingselskaber
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
0M
2019
EBITDA
DKK millions
0M
3M
7M
10M
14M
3M
2016
0M
2017
12M
2018
0M
2019
Income statement
DKK thousands
Item
2016
2017
2018
2019
Revenue
-20
-16
-17
-17
Staff expenses
-0
-0
-0
-0
EBITDA
3.189
454
11.813
-17
Depreciation & amort.
-0
-0
-0
-0
EBIT
3.189
454
11.813
-17
Net financials
3.209
469
9.363
9.589
Profit before tax
3.198
461
10.439
9.572
Tax
4
3
546
2.106
Net profit
3.193
457
9.892
7.466
Balance sheet
DKK thousands
Item
2016
2017
2018
2019
Total assets
6.870
7.327
17.237
26.197
Equity
6.803
7.260
17.153
24.619
Long-term debt
0
0
0
0
Short-term debt
67
67
84
1.578
Total debt
67
67
84
1.578
Financial ratios
5-year trend
EBITDA margin
-1700000.0%
This company
15.8%
Market median
-10759594% vs market
2016
2019
Equity ratio
94.0%
This company
38.2%
Market median
+146% vs market
2016
2019
Return on equity
30.3%
This company
18.4%
Market median
+65% vs market
2016
2019
Net profit margin
746634400.0%
This company
8.1%
Market median
+9217708542% vs market
2016
2019
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
2016
2019
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2016
2019
Annual reports & filings
Annual report 2019
Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
View
PDF
Annual report 2017
Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
View
PDF
Annual report 2016
Filed via CVR / Virk · Period 2016-05-18 – 2016-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
KB
Kaspar Basse
Management
Management
2016
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
KAB II 2016 ApS
Company
66.7%
66.7%
2017
KAB ApS
Company
90.0%
90.0%
2016
MUDHONEY HOLDINGS ApS
Company
10.0%
10.0%
2017
HP HOLDING 2001 ApS
Company
10.0%
10.0%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of KAB Biotech Holding ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Kaspar Basse
Management
0 companies